main content start

Homepage

Our Login / Registration service is temporarily unavailable, due to technical issue.

Latest Videos

Latest Videos

Brightcove Home Latest Listing

Breast Cancer

Prostate Cancer

Multiple Myeloma

Multiple Myeloma

Brightcove Cards Listing

Popular on MedEnrich

Popular in No name
  • Myelodysplastic Syndromes3m 18s

    Anemia of MDS

    Anemia is common feature of MDS with 90% patients having anemia at diagnosis or initial presentation. Anemia not only impacts quality of life but is also prognostic in nature.
    anemia mds transfusion dependence
  • Myelodysplastic Syndromes8m 45s

    Current Challenges in MDS Diagnosis and Consequences

    Bone marrow examination-based diagnosis of MDS with either biopsy or aspirate remains standard of care but is associated with pain, bleeding, difficulty to use the same in elderly patients and hIgh interobserver variability.
    non invasive mds diagnosis web based mds diagnosis tools
  • Breast Cancer14m 46s

    ESMO 2022 Breast Cancer Comprehensive Coverage

    View comprehensive coverage of Breast Cancer from ESMO 2022
    dose dense adjuvant chemotherapy esmo keynote -522 monarch -3 study
  • Multiple Myeloma10m 19s

    CAR -T cells in Lymphoma

    CAR-T cell therapies are approved for treatment of Diffuse Large B Cell Lymphoma (DLBCL) , Follicular Lymphoma & Mantle Cell Lymphoma.
    car-t cell therapy high risk lymphoma
  • Oncology3m 36s

    Tissue Agnostic Treatment options in Solid Tumors

    Tissue-agnostic treatment based on shared genetic aberrations have provided a new direction in cancer treatment. Emerging clinical evidence indicates that many molecular aberrations can be common across tumor types with different site of origin.
    personalized medicine precision medicine tissue agnostic treatment
  • Breast Cancer12m 37s

    Best practices for side effect management and patient monitoring with Palbociclib

    Effective management of Palbociclib's side effects involves regular monitoring of blood counts to detect neutropenia, along with managing symptoms like fatigue, nausea, and infections.
    side effects patient monitoring cdk4/6 inhibitors palbociclib
  • Multiple Myeloma8m 2s

    EHA 2022 Updates : Multiple Myeloma

    EHA 2022 saw exciting progress particularly from the perspective of Bispecific Antibodies showing encouraging response rates in relapsed / refractory setting of Multiple Myeloma.
    bcma targeting bispecific antibodies pneumocystis jirovecii pneumonia
  • Multiple Myeloma9m 20s

    Integrating Pomalidomide Based Regimens in Multiple Myeloma

    Integrating pomalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (RRMM) involves using them as a core regimen, often combined with other agents like bortezomib or monoclonal antibodies for enhanced efficacy.
    pomalidomide-dexamethasone rrmm management progression-free survival combination therapies
  • Breast Cancer17m 33s

    Outcome of Palbociclib based combination therapy vs endocrine monotherapy in real world setting

    In real-world settings, Palbociclib-based combination therapy demonstrates improved progression-free survival and clinical benefit rates compared to endocrine monotherapy in HR+/HER2- advanced breast cancer.
    palbociclib endocrine monotherapy hr+/her2- advanced breastcancer palbociclib based combinations
  • Myelodysplastic Syndromes17m 59s

    Genomics of AML -Therapeutic and Prognostic Implications

    ~40% of AML patients have targetable mutations. Younger patients often have FLT3-ITD or FLT3- TKD mutation. Mutations IDH-1 , IDH-2 & t-53 mutations are more common in elderly patients.
    idh 1& 2 mutations flt3-tkd mutations bcl2 inhibtors genomics of aml
  • For Pharmacist

    For Pharmacist

    Brightcove Cards Listing

    Webinars

    Webinar Cards Listing

    Upcoming Webinar

    Upcoming Webinar

    MedBytes

    MedBytes

    Medbytes Cards Listing
    Hi, can I help?
    Chat SupportX
    Support Team
    Hello, how can I help you today?
    Please select one of the below options.

    Find Information

    Unable to Login or Register

    Want to share feedback